𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Whom to license patented technology

✍ Scribed by Sang-Seung Yi


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
80 KB
Volume
19
Category
Article
ISSN
0143-6570

No coin nor oath required. For personal study only.

✦ Synopsis


This paper examines the optimal licensing policy of a patent holder when potential licensees differ in their capacities in absorbing the patented technology. If two-part tariffs with non-negative royalties and fixed fees are feasible, the patent holder finds it optimal to license the strong firm exclusively whether or not an exclusive licensing of the weak firm deters the strong firm from entering the market. Hence, the potential trade-offs between strategic gains associated with licensing to weak competitors and efficiency gains associated with licensing to efficient competitors do not exist when two part tariffs are available.


πŸ“œ SIMILAR VOLUMES


Rentech to license floating GTL technolo
πŸ“‚ Article πŸ“… 2003 πŸ› Elsevier Science βš– 31 KB

R&D costs rose by 5% to DKR 713 M for 2002. The group generated profit of DKR 644 M after tax for 2002. Headquartered in Denmark, Novozymes A/S is a biotech-based world leader in enzymes and microorganisms for industrial use. Novozymes also applies its core competences in selected pharmaceutical are